Tuesday, 29 October 2013

Bentham Science Controversy- Peer Review

Bentham Science- a recognized and reputable name in the STM publishing industry which integrate 116 online and print journals, 300 eBooks; 260 of which are indexed by Scopus and 230 free to view-Open Access online journals. The prominent journals of Bentham science comprise of 30 renowned, high impact titles. These high impact titles include, Current Molecular Medicine, Current Drug Metabolism, Current Medicinal Chemistry, Current Pharmaceutical Design, and Current Cancer Drug Targets.

Maintaining that of a repute in any business at times leads to challenges, simply because the more you are actually eminent, the more conflict would come your way. There have been accusations entirely against Bentham Open during the past; however they weren’t able to affirm anything at all worthwhile. Bentham Science is surely a recognized name in the field of Publishing, with a wide range of substantially peer reviewed Open Access journals addressing key disciplines of technology, medicine, science and social sciences.
The publishers at Bentham Science adhere to single-blind peer review method while evaluating manuscripts that guarantees impartiality and objectivity.  Every Open Access journal features an independent referee and Editorial Board who normally are responsible for evaluating manuscripts carefully and thoroughly. Furthermore, authors publishing with Bentham are able to retain their copyrights to their published written content. Bentham Open-Access matches the international standards of peer review and publications.

No comments:

Post a Comment